Apoptotic and Nonapoptotic Activities of Pterostilbene against Cancer

Rong-Jane Chen1, Hsiao-Che Kuo2, Li-Hsin Cheng3

  • 1Department of Food Safety/Hygiene and Risk Management, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan. janekhc@gmail.com.

Insights

Pterostilbene (PS) shows promise as an alternative cancer treatment, combating drug resistance and metastasis. This natural compound may be a valuable dietary supplement for cancer prevention and therapy.

Area of Science:

  • Oncology
  • Pharmacology
  • Nutritional Science

Background:

  • Cancer remains a leading cause of mortality worldwide.
  • Current cancer therapies can lead to drug resistance and metastatic recurrence, necessitating alternative strategies.
  • Pterostilbene (PS) is a natural compound with demonstrated anti-cancer properties.

Purpose of the Study:

  • To review the progression of tumors towards metastasis.
  • To summarize the anti-cancer activities of pterostilbene (PS).
  • To explore the potential clinical applications of PS as a novel cancer therapeutic.

Main Methods:

  • Literature review of tumor metastasis.
  • Systematic review of studies on pterostilbene's anti-cancer effects.
  • Analysis of current research on pterostilbene's pharmacological benefits.

Main Results:

  • Pterostilbene (PS) exhibits potent anti-cancer activities, including apoptosis induction.
  • PS demonstrates efficacy in preventing and treating various cancer stages.
  • Evidence suggests PS can counteract metastatic progression.

Conclusions:

  • Pterostilbene (PS) is a promising alternative medicine for cancer treatment.
  • PS can be utilized as a nutritional supplement for cancer prevention and therapy.
  • Further clinical research is warranted to establish PS as a standard therapeutic agent.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.7K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.2K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.6K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.2K